BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7921003)

  • 1. GH regulation in acromegaly.
    Liuzzi A; Oppizzi G; Cozzi R; Dallabonzana D; Petroncini M; Orlandi P; Chiodini PG
    J Pediatr Endocrinol; 1993; 6(3-4):339-43. PubMed ID: 7921003
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyrotrophin-releasing hormone: a growth hormone-releasing factor.
    Harvey S
    J Endocrinol; 1990 Jun; 125(3):345-58. PubMed ID: 2115567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
    Riedel M; Günther T; von zur Mühlen A; Brabant G
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural regulation of growth hormone secretion.
    Martin JB
    Med Clin North Am; 1978 Mar; 62(2):327-36. PubMed ID: 347196
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth hormone neuroregulation and the clinical relevance of somatostatin.
    Wass JA
    Clin Endocrinol Metab; 1983 Nov; 12(3):695-724. PubMed ID: 6142779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.
    Lamberts SW; Verleun T; Oosterom R
    J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of growth hormone secretion in man: a review.
    Johnston DG; Davies RR; Prescott RW
    J R Soc Med; 1985 Apr; 78(4):319-27. PubMed ID: 2858590
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly.
    Ho PJ; Friberg RD; Barkan AL
    J Clin Endocrinol Metab; 1992 Sep; 75(3):812-9. PubMed ID: 1517371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological role of somatostatin in regulation of pulsatile growth hormone secretion.
    Tannenbaum GS
    Adv Exp Med Biol; 1985; 188():229-59. PubMed ID: 2863934
    [No Abstract]   [Full Text] [Related]  

  • 10. Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administration.
    Pieters GF; Smals AE; Hermus AR; Smals AG; Benraad TJ; Kloppenborg PW
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):701-7. PubMed ID: 6150772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of hypothalamic hormones in the control of growth hormone secretion and of growth.
    Frohman LA
    Acta Paediatr Scand Suppl; 1988; 343():3-11. PubMed ID: 2904204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone: inhibitory function on growth hormone through both somatostatin and growth hormone-releasing factor neurons.
    Willoughby JO; Kapoor R; Pepin S
    Neuropeptides; 1994 Oct; 27(4):217-23. PubMed ID: 7808594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Suppression by dopamine of GH release induced by GRF in a case of acromegaly].
    Matsubara M; Odagaki E; Morioka T
    Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):193-7. PubMed ID: 3111898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin and growth hormone releasing factor: synthesis, location, metabolism and function.
    Gómez-Pan A; Rodriguez-Arnao MD
    Clin Endocrinol Metab; 1983 Nov; 12(3):469-507. PubMed ID: 6142777
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of actively immunizing sheep against growth hormone-releasing hormone or somatostatin on spontaneous pulsatile and neostigmine-induced growth hormone secretion.
    Magnan E; Mazzocchi L; Cataldi M; Guillaume V; Dutour A; Dadoun F; Le Bouc Y; Sauze N; Renard M; Conte-Devolx B
    J Endocrinol; 1995 Jan; 144(1):83-90. PubMed ID: 7891028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of atropine on growth hormone release in normal subjects and acromegaly.
    Zhang J; Lu JM; Huang ZJ
    Chin Med J (Engl); 1989 Jan; 102(1):45-7. PubMed ID: 2504552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone hypersecretion and acromegaly.
    Daughaday WH; Cryer PE
    Hosp Pract; 1978 Aug; 13(8):75-80. PubMed ID: 99362
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of calcitonin-induced growth hormone (GH) suppression: roles of somatostatin and GH-releasing factor.
    Lengyel AM; Tannenbaum GS
    Endocrinology; 1987 Apr; 120(4):1377-83. PubMed ID: 2881773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic hormone interaction in acromegaly.
    Gomez-Pan A; Tunbridge WM; Duns A; Hall R; Besser GM; Coy DH; Schally AV; Kastin AJ
    Clin Endocrinol (Oxf); 1975 Sep; 4(5):455-60. PubMed ID: 170027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.